Concepedia

Author

Angela Cramer

University of ManchesterORCID

Also Known As

A CRAMER, A Cramer, A R Cramer, A. Cramer, A. R. Cramer, Andrew Cramer, Angela Cramer, Annaliese Cramer

73

Publications

687

Citations

10

H-Index

24

Concepts

All Affiliations

University of ManchesterThe Christie HospitalCancer Research UK Manchester InstituteThe Christie NHS Foundation TrustWythenshawe Hospital
AC

About

Angela Cramer is an author at University of Manchester specializing in medicine, pathology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

270

2

Engineering

1

1

110

3

Health Sciences

1

1

22

4

Cell Biology

1

1

138

5

Epidemiology

1

1

22

Angela Cramer

×

10

Publications

648

Citations

10

H-Index

YearCitations

Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma <i>In situ</i> of the Breast

Nicola Barnes, Sahar Khavari, G.P. Boland,

Clinical Cancer Research

2005

138

Molecular phenotypes of DCIS predict overall and invasive recurrence

Kathryn Williams, N L P Barnes, Angela Cramer,

Annals of Oncology

2015

110

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for <i>BRCA1</i> and <i>BRCA2</i> testing

D. Gareth Evans, Fiona Lalloo, Angela Cramer,

Journal of Medical Genetics

2009

95

Insights from Studies with Oral Cleft Genes Suggest Associations between WNT-pathway Genes and Risk of Oral Cancer

Pedro A. Andrade Filho, Ariadne Letra, Angela Cramer,

Journal of Dental Research

2011

90

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

G. Wilson, Angela Cramer, Arkadiusz Welman,

British Journal of Cancer

2006

74

Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma <i>In situ</i> Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial

Nigel Bundred, Angela Cramer, Julie Morris,

Clinical Cancer Research

2010

40

FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity

S Timbrell, H Aglan, Angela Cramer,

npj Breast Cancer

2021

29

Short‐term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma

R. Prasad, G.P. Boland, Angela Cramer,

Cancer

2003

28

Effects of acute and chronic low density lipoprotein exposure on neutrophil function

Tatsiana Palvinskaya, MaryEllen Antkowiak, Elianne Burg,

Pulmonary Pharmacology & Therapeutics

2012

22

The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers

Ángela Lamarca, Salvatore Galdy, Jorge Barriuso,

PLoS ONE

2018

22

Page 1